Bogart Wealth LLC cut its position in CME Group Inc. (NASDAQ:CME - Free Report) by 10.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,627 shares of the financial services provider's stock after selling 7,083 shares during the quarter. CME Group comprises 0.7% of Bogart Wealth LLC's investment portfolio, making the stock its 23rd biggest position. Bogart Wealth LLC's holdings in CME Group were worth $15,288,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of CME. Sigma Planning Corp raised its position in shares of CME Group by 23.3% during the 1st quarter. Sigma Planning Corp now owns 13,178 shares of the financial services provider's stock valued at $3,496,000 after buying an additional 2,489 shares in the last quarter. Catalyst Financial Partners LLC raised its position in shares of CME Group by 3.6% during the 1st quarter. Catalyst Financial Partners LLC now owns 1,712 shares of the financial services provider's stock valued at $454,000 after buying an additional 59 shares in the last quarter. Signaturefd LLC raised its position in shares of CME Group by 3.9% during the 1st quarter. Signaturefd LLC now owns 5,458 shares of the financial services provider's stock valued at $1,448,000 after buying an additional 204 shares in the last quarter. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of CME Group during the 1st quarter valued at $5,058,000. Finally, Bleakley Financial Group LLC raised its position in shares of CME Group by 76.4% during the 1st quarter. Bleakley Financial Group LLC now owns 22,151 shares of the financial services provider's stock valued at $5,876,000 after buying an additional 9,593 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Trading Down 1.3%
CME Group stock traded down $3.48 during trading hours on Tuesday, reaching $273.58. The stock had a trading volume of 433,611 shares, compared to its average volume of 2,171,528. The stock has a market cap of $98.59 billion, a PE ratio of 27.49, a PEG ratio of 4.45 and a beta of 0.44. CME Group Inc. has a 52 week low of $193.25 and a 52 week high of $290.79. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a fifty day simple moving average of $276.47 and a 200-day simple moving average of $259.81.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same period last year, the company posted $2.50 EPS. The company's quarterly revenue was up 10.4% compared to the same quarter last year. Analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were given a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.83%. CME Group's dividend payout ratio is 50.30%.
Analysts Set New Price Targets
Several research firms have recently weighed in on CME. JPMorgan Chase & Co. lowered their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday. Citigroup increased their target price on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. Finally, Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, CME Group presently has a consensus rating of "Hold" and an average price target of $261.80.
View Our Latest Analysis on CME Group
Insider Transactions at CME Group
In related news, General Counsel Jonathan L. Marcus sold 390 shares of CME Group stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the transaction, the general counsel directly owned 6,708 shares of the company's stock, valued at $1,861,470. This trade represents a 5.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the transaction, the director directly owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is owned by corporate insiders.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.